These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


312 related items for PubMed ID: 9386175

  • 1. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro.
    Magga J, Vuolteenaho O, Marttila M, Ruskoaho H.
    Circulation; 1997 Nov 04; 96(9):3053-62. PubMed ID: 9386175
    [Abstract] [Full Text] [Related]

  • 2. Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release.
    Leskinen H, Vuolteenaho O, Ruskoaho H.
    Circ Res; 1997 Jan 04; 80(1):114-23. PubMed ID: 8978330
    [Abstract] [Full Text] [Related]

  • 3. Direct left ventricular wall stretch activates GATA4 binding in perfused rat heart: involvement of autocrine/paracrine pathways.
    Hautala N, Tenhunen O, Szokodi I, Ruskoaho H.
    Pflugers Arch; 2002 Jan 04; 443(3):362-9. PubMed ID: 11810204
    [Abstract] [Full Text] [Related]

  • 4. Endothelin-1 and angiotensin II contribute to BNP but not c-fos gene expression response to elevated load in isolated mice hearts.
    Piuhola J, Szokodi I, Ruskoaho H.
    Biochim Biophys Acta; 2007 Mar 04; 1772(3):338-44. PubMed ID: 17188849
    [Abstract] [Full Text] [Related]

  • 5. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats.
    Magga J, Marttila M, Mäntymaa P, Vuolteenaho O, Ruskoaho H.
    Endocrinology; 1994 Jun 04; 134(6):2505-15. PubMed ID: 8194476
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
    Magga J, Kalliovalkama J, Romppanen H, Vuolteenaho O, Pörsti I, Kähönen M, Tolvanen JP, Ruskoaho H.
    J Hypertens; 1999 Nov 04; 17(11):1543-52. PubMed ID: 10608466
    [Abstract] [Full Text] [Related]

  • 7. Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension.
    Bianciotti LG, de Bold AJ.
    Cardiovasc Res; 2001 Mar 04; 49(4):808-16. PubMed ID: 11230980
    [Abstract] [Full Text] [Related]

  • 8. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
    Kaddoura S, Firth JD, Boheler KR, Sugden PH, Poole-Wilson PA.
    Circulation; 1996 Jun 01; 93(11):2068-79. PubMed ID: 8640984
    [Abstract] [Full Text] [Related]

  • 9. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes.
    Harada M, Itoh H, Nakagawa O, Ogawa Y, Miyamoto Y, Kuwahara K, Ogawa E, Igaki T, Yamashita J, Masuda I, Yoshimasa T, Tanaka I, Saito Y, Nakao K.
    Circulation; 1997 Nov 18; 96(10):3737-44. PubMed ID: 9396478
    [Abstract] [Full Text] [Related]

  • 10. Pressure overload increases GATA4 binding activity via endothelin-1.
    Hautala N, Tokola H, Luodonpää M, Puhakka J, Romppanen H, Vuolteenaho O, Ruskoaho H.
    Circulation; 2001 Feb 06; 103(5):730-5. PubMed ID: 11156886
    [Abstract] [Full Text] [Related]

  • 11. Endothelin-1 contributes to the Frank-Starling response in hypertrophic rat hearts.
    Piuhola J, Szokodi I, Kinnunen P, Ilves M, deChâtel R, Vuolteenaho O, Ruskoaho H.
    Hypertension; 2003 Jan 06; 41(1):93-8. PubMed ID: 12511536
    [Abstract] [Full Text] [Related]

  • 12. Involvement of transcriptional and posttranscriptional mechanisms in cardiac overload-induced increase of B-type natriuretic peptide gene expression.
    Magga J, Vuolteenaho O, Tokola H, Marttila M, Ruskoaho H.
    Circ Res; 1997 Nov 06; 81(5):694-702. PubMed ID: 9351443
    [Abstract] [Full Text] [Related]

  • 13. Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure.
    Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Nicholls MG, Richards AM.
    Clin Sci (Lond); 2004 Jun 06; 106(6):569-76. PubMed ID: 14723602
    [Abstract] [Full Text] [Related]

  • 14. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and 'overdrive' of the endothelin system.
    Yamamoto K, Masuyama T, Sakata Y, Doi R, Ono K, Mano T, Kondo H, Kuzuya T, Miwa T, Hori M.
    Cardiovasc Res; 2000 Jun 06; 46(3):421-32. PubMed ID: 10912453
    [Abstract] [Full Text] [Related]

  • 15. Endogenous angiotensin II suppresses stretch-induced ANP secretion via AT1 receptor pathway.
    Oh YB, Gao S, Shah A, Kim JH, Park WH, Kim SH.
    Peptides; 2011 Feb 06; 32(2):374-81. PubMed ID: 21056071
    [Abstract] [Full Text] [Related]

  • 16. Key roles of endothelin-1 and p38 MAPK in the regulation of atrial stretch response.
    Kerkelä R, Ilves M, Pikkarainen S, Tokola H, Ronkainen VP, Majalahti T, Leppäluoto J, Vuolteenaho O, Ruskoaho H.
    Am J Physiol Regul Integr Comp Physiol; 2011 Jan 06; 300(1):R140-9. PubMed ID: 21084678
    [Abstract] [Full Text] [Related]

  • 17. Selective changes in natriuretic peptide and early response gene expression in isolated rat atria following stimulation by stretch or endothelin-1.
    Bruneau BG, de Bold AJ.
    Cardiovasc Res; 1994 Oct 06; 28(10):1519-25. PubMed ID: 8001040
    [Abstract] [Full Text] [Related]

  • 18. Role of cardiac nonmyocytes in cyclic mechanical stretch-induced myocyte hypertrophy.
    Harada M, Saito Y, Nakagawa O, Miyamoto Y, Ishikawa M, Kuwahara K, Ogawa E, Nakayama M, Kamitani S, Hamanaka I, Kajiyama N, Masuda I, Itoh H, Tanaka I, Nakao K.
    Heart Vessels; 1997 Oct 06; Suppl 12():198-200. PubMed ID: 9476582
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Z, Wang Y, Mizuno T, Ueki K, Tobe K, Kadowaki T.
    Circulation; 1994 May 06; 89(5):2204-11. PubMed ID: 8181146
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels.
    Ferron L, Capuano V, Ruchon Y, Deroubaix E, Coulombe A, Renaud JF.
    Circ Res; 2003 Dec 12; 93(12):1241-8. PubMed ID: 14615287
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.